| Pharmaceutical active ingredients: |
| Griseofulvin Microcrystalline |
| Available forms, composition and doses of Griseofulvin: |
| Suspension; Oral; Griseofulvin, Microcrystalline 125 mg / 5 ml |
| Griseofulvin medical category: |
| Human:Antifungals |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D01AA08 - GriseofulvinD01BA01 - Griseofulvin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Actavis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Fulcin S | Griseofulvin Microcrystalline | AstraZeneca |
| Grifulvin V | Griseofulvin Microcrystalline | Johnson & Johnson; Ortho McNeil Pharmaceuticals |
| Grisactin | Griseofulvin Microcrystalline | Wyeth; CFL Pharmaceuticals |
| Grisactin Forte | Griseofulvin Microcrystalline | Wyeth; CFL Pharmaceuticals |
| Griseofort | Griseofulvin Microcrystalline | Schering-Plough |
| Griseofulvin | Griseofulvin Microcrystalline | Stiefel Laboratories |
| Griseofulvina | Griseofulvin Microcrystalline | Chile Laboratorios |
| Grisoral | Griseofulvin Microcrystalline | Bal Pharma |
| Rexavin | Griseofulvin Microcrystalline | Ifars Pharmaceutical Laboratories |
| Fulvicin P / G | Griseofulvin Ultramicrocrystalline | Bayer Schering Pharma |